1999
DOI: 10.1006/prep.1999.1121
|View full text |Cite
|
Sign up to set email alerts
|

Expression and Partial Purification of a Recombinant Secretory Form of Human Liver Carboxylesterase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2008
2008
2014
2014

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 38 publications
(40 reference statements)
0
4
0
Order By: Relevance
“…CES1 HIEL and CES2 HTEL C-terminal sequences, and similar tetrapeptide sequences, have been previously shown to direct the microlocalization of mammalian liver CES within the endoplasmic reticulum (Robbi and Beaufay, 1991). Miller and coworkers (1999) have modified this sequence for human CES1 using site-directed mutagenesis to that of HIER, substituting the C-terminal leucine with arginine, and observed that the enzyme was secreted rather than retained within the cultured cells examined. Human and other mammalian CES5 sequences normally have a long hydrophobic C-terminal sequence which apparently provides the trigger for secretion.…”
Section: Ces5 Functional Aspectsmentioning
confidence: 99%
“…CES1 HIEL and CES2 HTEL C-terminal sequences, and similar tetrapeptide sequences, have been previously shown to direct the microlocalization of mammalian liver CES within the endoplasmic reticulum (Robbi and Beaufay, 1991). Miller and coworkers (1999) have modified this sequence for human CES1 using site-directed mutagenesis to that of HIER, substituting the C-terminal leucine with arginine, and observed that the enzyme was secreted rather than retained within the cultured cells examined. Human and other mammalian CES5 sequences normally have a long hydrophobic C-terminal sequence which apparently provides the trigger for secretion.…”
Section: Ces5 Functional Aspectsmentioning
confidence: 99%
“…Some carboxylesterases from animals, plants, and insects have been purified, characterized and used to degrade malathion (Miller et al 1999; Yoshii et al 2007b; Cao et al 2008). Several malathion-degrading strains have been isolated, and degradation studies have also been carried out (Foster and Bia 2004; Hashmi et al 2004; Goda et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…The bovine CES1.2A C-terminus lacks this sequence however which may alter the distribution characteristics for this enzyme. Miller and coworkers (1999) have described a bioengineered form of human CES1 for which the His-Ile-Glu-Leu was changed with a replacement Arginine at the C-terminus. This resulted in the secretion of this enzyme from human 293T cells in comparison with the native enzyme which was retained within the endoplasmic reticulum.…”
Section: Discussionmentioning
confidence: 99%